Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Summary of Outstandng Stock Options) (Details)

v3.19.1
Stockholders' Equity (Summary of Outstandng Stock Options) (Details)
3 Months Ended
Mar. 31, 2019
$ / shares
shares
Options Outstanding  
Balance | shares 3,008,754
Weighted Average Remaining Contractual Life (Years) 9 years 4 months 24 days
Weighted Average Exercise Price | $ / shares $ 2.66
Options Vested and Exercisable  
Balance | shares 1,256,273
Weighted Average Remaining Contractual Life (Years) 9 years
Weighted Average Exercise Price | $ / shares $ 4.28